| 000 | 01333 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512202243.0 | ||
| 264 | 0 | _c19840822 | |
| 008 | 198408s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1002/jps.2600730606 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKirsch, L E | |
| 245 | 0 | 0 |
_aPharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cJun 1984 |
||
| 300 |
_a728-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAncitabine _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aCytarabine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 700 | 1 | _aNotari, R E | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 73 _gno. 6 _gp. 728-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.2600730606 _zAvailable from publisher's website |
| 999 |
_c6204078 _d6204078 |
||